FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Tacrolimus Capsules
Status: Resolved
»Duration of Shortage: 05/17/2019 - 05/02/2022
»Therapeutic Categories: Transplant

Expand all

Accord Healthcare Inc. (Revised 05/02/2022)

Company Contact Information:
866-941-7875, option 2

Presentation
  • 0.5 mg 100 count (NDC 1672904101)
  • 1 mg 100 count (NDC 1672904201)
  • 5 mg 100 count (NDC 1672904301)
Note:
  • Available

Ascend Laboratories LLC. (Revised 05/02/2022)

Company Contact Information:
860-667-7081

Presentation
  • 0.5 mg 100’s count (NDC 67877-278-01)
  • 1 mg 100’s count (NDC 67877-279-01)
  • 5 mg 100’s count (NDC 67877-280-01)
Note:
  • Available

Astellas (Revised 05/02/2022)

Company Contact Information:
800-727-7003

Presentation
  • PROGRAF® (tacrolimus) capsules 0.5 mg 100 count bottle (NDC 0469-0607-73)
  • PROGRAF® (tacrolimus) capsules 5 mg 100 count bottle (NDC 0469-0657-73)
  • PROGRAF® (tacrolimus) capsules 1 mg 100 count bottle (NDC 0469-0617-73)
  • ASTAGRAF XL® (tacrolimus extended release capsules) 0.5 mg 30 count bottle (NDC 0469-0647-73)
  • ASTAGRAF XL® (tacrolimus extended release capsules) 1 mg 30 count bottle (NDC 0469-0677-73)
  • ASTAGRAF XL® (tacrolimus extended release capsules) 5 mg 30 count bottle (NDC 0469-0687-73)
  • PROGRAF® Granules (tacrolimus for oral suspension) 0.2 mg unit dose packets (NDC 0469-1230-50)
  • PROGRAF® Granules (tacrolimus for oral suspension) 1 mg unit dose packets (NDC 0469-1330-50)
Note:
  • Available

BPI Labs, LLC (Revised 05/02/2022)

Company Contact Information:
727-471-0850 ext. 275

Presentation
  • 1 mg 100 count bottle (NDC 54288-135-01)
Note:
  • Available

Dr. Reddy's Laboratories, Inc. (Revised 05/02/2022)

Company Contact Information:
866-733-3952

Presentation
  • 0.5 mg (NDC 55111-525-01)
  • 1 mg (NDC 55111-526-01)
  • 5 mg (NDC 55111-527-01)
Note:
  • Available

Glenmark Pharmaceuticals (Revised 05/02/2022)

Company Contact Information:
888-721-7115

Presentation
  • 0.5 mg 100 count bottles (NDC 68462-685-01)
  • 1 mg 100 count bottles (NDC 68462-686-01)
  • 5 mg 100 count bottles (NDC 68462-687-01)
Note:
  • Available

Mylan Pharmaceuticals Inc., a Viatris Company (Revised 05/02/2022)

Company Contact Information:
800-796-9526

Presentation
  • 0.5 mg, 100s (NDC 0378-2045-01)
  • 1 mg, 100s (NDC 0378-2046-01)
  • 5 mg, 100s (NDC 0378-2047-01)
Note:
  • Available

Sandoz (Revised 05/02/2022)

Company Contact Information:
800-525-8747

Presentation
  • 0.5 mg 100 count bottle (NDC 0781-2102-01)
  • 1 mg 100 count bottle (NDC 0781-2103-04)
  • 5 mg 100 count bottle (NDC 0781-2104-01)
Note:
  • Available

Strides Pharma Inc. (Revised 05/02/2022)

Company Contact Information:
855-273-0146

Presentation
  • 1 mg 100 count bottles (NDC 64338-721-06)
  • 0.5 mg 100 count bottles (NDC 64380-720-06)
  • 5 mg 100 count bottles (NDC 64380-722-06)
Note:
  • Available

Veloxis Pharmaceuticals, Inc. (Revised 05/02/2022)

Company Contact Information:
919-591-3085

Presentation
  • Envarsus XR 0.75 mg Extended-Release Tablets 30 count (NDC 68992-3075-3)
  • Envarsus XR 0.75 mg Extended-Release Tablets 100 count (NDC 68992-3075-1)
  • Envarsus XR 1 mg Extended-Release Tablets 30 count (NDC 68992-3010-3)
  • Envarsus XR 1 mg Extended-Release Tablets 100 count (NDC 68992-3010-1)
  • Envarsus XR 4 mg Extended-Release Tablets 30 count (NDC 68992-3040-3)
  • Envarsus XR 4 mg Extended-Release Tablets 100 count (NDC 68992-3040-1)
Note:
  • Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English